Effectiveness of NephroCheckTM Test to Predict Acute Kidney Injury Following Advanced Cardiac Replacement Therapies

Completed

Conditions studied: Acute Kidney Injury, Heart Failure

In brief

The purpose of this study is to test how well the NephroCheckTM Test, a noninvasive laboratory test performed on urine, predicts loss of kidney function in patients that have had a heart transplant or a Left Ventricular Assist Device (LVAD) or Total Artificial Heart (TAH) implanted.

Key facts

Study ID

NCT02827448

Run by

Baylor Research Institute

People needed

300

Starts

2015-11-01

Expected to finish

2018-06-01

Last updated by the study team

2019-07-11

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who will receive LVAD or heart transplantation

You may not qualify if…

• Patients who are unable to give consent

Where it is running

• Baylor Research Institute — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.